DD284027A5 - Verfahren zur herstellung von renininhibitoren - Google Patents

Verfahren zur herstellung von renininhibitoren Download PDF

Info

Publication number
DD284027A5
DD284027A5 DD89330012A DD33001289A DD284027A5 DD 284027 A5 DD284027 A5 DD 284027A5 DD 89330012 A DD89330012 A DD 89330012A DD 33001289 A DD33001289 A DD 33001289A DD 284027 A5 DD284027 A5 DD 284027A5
Authority
DD
German Democratic Republic
Prior art keywords
cha
ala
carbon atoms
lead
compound
Prior art date
Application number
DD89330012A
Other languages
German (de)
English (en)
Inventor
Jan O Karlsson
Erik M H Sohtell
Rolf Ch Westerlund
Original Assignee
�����@������������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@������������������k�� filed Critical �����@������������������k��
Publication of DD284027A5 publication Critical patent/DD284027A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DD89330012A 1988-06-28 1989-06-27 Verfahren zur herstellung von renininhibitoren DD284027A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8802428A SE8802428D0 (sv) 1988-06-28 1988-06-28 New compounds

Publications (1)

Publication Number Publication Date
DD284027A5 true DD284027A5 (de) 1990-10-31

Family

ID=20372758

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89330012A DD284027A5 (de) 1988-06-28 1989-06-27 Verfahren zur herstellung von renininhibitoren

Country Status (14)

Country Link
EP (1) EP0353211A1 (xx)
JP (1) JPH0285245A (xx)
KR (1) KR900000383A (xx)
CN (1) CN1039028A (xx)
AU (1) AU3671189A (xx)
DD (1) DD284027A5 (xx)
DK (1) DK300989A (xx)
FI (1) FI893118A (xx)
HU (1) HUT51291A (xx)
NO (1) NO892564L (xx)
PT (1) PT90992A (xx)
SE (1) SE8802428D0 (xx)
YU (1) YU132789A (xx)
ZA (1) ZA894544B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009838A1 (en) * 1989-12-22 1991-07-11 Aktiebolaget Astra New amides
US5317039A (en) * 1992-07-20 1994-05-31 G. D. Searle & Co. Cyclopropyl-alanine aryl/alkylsulfide/sulfonyl-terminated amino-diol compounds for treatment of hypertension
US5314920A (en) * 1992-07-20 1994-05-24 G. D. Searle & Co. Ethynyl-alanine aryl/alkylsulfonyl-terminated amino-diol compounds for treatment of hypertension
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
KR20010088472A (ko) * 2001-07-19 2001-09-28 이강섭 석재, 철, 콘크리트, 목재, 플라스틱 등 기존의 모든물건의 바탕에 자연적으로 대리석 무늬를 형성하는 공법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645759A (en) * 1984-06-22 1987-02-24 Abbott Laboratories Renin inhibiting compounds
WO1987004349A1 (en) * 1986-01-16 1987-07-30 Joseph Dellaria Peptide analogs
EP0321497A1 (en) * 1986-09-30 1989-06-28 The Upjohn Company Renin inhibitory peptides having novel c-terminal moieties
SE8605573D0 (sv) * 1986-12-29 1986-12-29 Haessle Ab Novel compounds

Also Published As

Publication number Publication date
DK300989A (da) 1989-12-29
KR900000383A (ko) 1990-01-30
FI893118A (fi) 1989-12-29
DK300989D0 (da) 1989-06-19
NO892564D0 (no) 1989-06-21
AU3671189A (en) 1990-01-04
CN1039028A (zh) 1990-01-24
JPH0285245A (ja) 1990-03-26
SE8802428D0 (sv) 1988-06-28
HUT51291A (en) 1990-04-28
PT90992A (pt) 1989-12-29
NO892564L (no) 1989-12-29
ZA894544B (en) 1990-07-25
YU132789A (sh) 1992-09-07
EP0353211A1 (en) 1990-01-31
FI893118A0 (fi) 1989-06-27

Similar Documents

Publication Publication Date Title
DE3789371T2 (de) Aryloxy- und Arylacyloxymethyl-Ketone als Thiolprotease-Hemmungsstoffe.
EP0090341B1 (de) Spiro(4.(3+n))-2-aza-alkan-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
DE69404324T2 (de) Matrix metallprotease inhibitoren
DE4004820A1 (de) Renininhibitoren, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3643977A1 (de) Harnstoff-derivate mit renin inhibierender wirkung
DD243932A5 (de) Verfahren zur herstellung von n,n'-dialkylguanidino-dipeptiden
EP0236872A2 (de) Hydroxylaminderivate, deren Herstellung und Verwendung für Heilmittel
EP0184550A2 (de) 5-Amino-4-hydroxyvalerylamid-Derivate
DD236522A5 (de) Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen
DE3246503A1 (de) Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
DE4003574A1 (de) Neue dipeptide, verfahren zu ihrer herstellung und ihre verwendung als renininhibitoren in arzneimitteln
EP0374097A2 (de) Verwendung von Peptidisosteren als retrovirale Proteasehemmer
DE69405572T2 (de) Matrix-metalloprotease inhibitoren
EP0374098A2 (de) Retrovirale Proteasehemmer
DE69314911T2 (de) Cis-epoxide Derivate, verwendbar als irreversible HIV-Protease Inhibitoren und Verfahren und Zwischenprodukte zu ihrer Herstellung
DE3606448A1 (de) Aminoalkanoylureidoamino- und -iminosaeure-verbindungen
DD284027A5 (de) Verfahren zur herstellung von renininhibitoren
DE4003575A1 (de) Retroisostere dipeptide, verfahren zur herstellung und ihre verwendung als renininhibitoren in arzneimitteln
AT390619B (de) Verfahren zur herstellung von neuen prolinderivaten
DE4026614A1 (de) Phosphonopyrrolidin- und piperidin-haltige pseudopeptide vom statintyp, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel gegen retroviren
DE69903620T2 (de) Alpha-aminophosphinopeptid-derivate und sie enthaltende zusammensetzungen
EP0391850B1 (de) Ungesättigte Aminodicarbonsäurederivate
EP0203450B1 (de) Neue Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
DE69020752T2 (de) Peptide, die eine reninhemmende Aktivität besitzen, deren Herstellung und Verwendung.
EP0279350B1 (de) Annelierte Azepinon- und Azocinon-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung, sowie Zwischenprodukte bei ihrer Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee
ENJ Ceased due to non-payment of renewal fee